180 Life Sciences: Funding, Investors & Team (Sep 2026)
180 Life Sciences Corp. is a biotechnology company in the clinical stage, specializing in creating innovative drugs to address gaps in the treatment of inflammatory diseases, fibrosis, and pain. The company draws on the knowledge and expertise of experts in therapeutic medicine from Oxford University, the Hebrew University, and Stanford University.
180 Life Sciences has raised $431M across 3 funding rounds on record, the most recent an undisclosed round of $425M announced in Jul 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
180 Life Sciences Company Profile and Key Stats
Latest funding round on record: Jul 2025.
180 Life Sciences Funding Rounds
180 Life Sciences raised $3.0M in an undisclosed round announced in Aug 2023.
1.3 years later, an undisclosed round of $2.9M was announced in Dec 2024.
7 months later, an undisclosed round of $425M was announced in Jul 2025.
180 Life Sciences Founders and Leadership Team
Contact details for the 180 Life Sciences team: 1 of 1 has an email address on file.
Start 14-day free trial →180 Life Sciences Funding Compared to Other Biotechnology Startups
180 Life Sciences' latest round of $425M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like 180 Life Sciences in Biotechnology and Menlo Park
Companies Similar to 180 Life Sciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
180 Life Sciences Funding FAQs
What does 180 Life Sciences do?
180 Life Sciences Corp. is a biotechnology company in the clinical stage, specializing in creating innovative drugs to address gaps in the treatment of inflammatory diseases, fibrosis, and pain. The company draws on the knowledge and expertise of experts in therapeutic medicine from Oxford University, the Hebrew University, and Stanford University.
How much funding has 180 Life Sciences raised?
180 Life Sciences has raised $431M across 3 rounds on record. The most recent is an undisclosed round of $425M announced in Jul 2025.
When did 180 Life Sciences last raise funding?
180 Life Sciences' most recent funding round on record is an undisclosed round of $425M, announced in Jul 2025.
Who founded 180 Life Sciences?
FundedIQ lists Jim Woody (Founder) at 180 Life Sciences.
Where is 180 Life Sciences headquartered?
180 Life Sciences is based in Menlo Park, California, United States.
How many employees does 180 Life Sciences have?
180 Life Sciences is in the 1-10 employee band.
How does 180 Life Sciences' funding compare to other Biotechnology startups?
180 Life Sciences' latest round of $425M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's 180 Life Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 180 Life Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.